Publications by authors named "Joy N Tsai"

20Publications

Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.

Authors:
Sabashini K Ramchand Natalie L David Hang Lee Michael Bruce Mary L Bouxsein Benjamin Z Leder Joy N Tsai

J Bone Miner Res 2021 Jan 19;36(1):41-51. Epub 2020 Sep 19.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.

View Article and Find Full Text PDF
January 2021

Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk.

Authors:
Laura C Torchen Joy N Tsai Prathima Jasti Rodrigo Macaya Ryan Sisk Matthew L Dapas M Geoffrey Hayes Margrit Urbanek Andrea Dunaif

Obesity (Silver Spring) 2020 01 14;28(1):106-113. Epub 2019 Nov 14.

Division of Endocrinology, Diabetes, and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article and Find Full Text PDF
January 2020

Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.

Authors:
Sabashini K Ramchand Natalie L David Benjamin Z Leder Joy N Tsai

J Clin Endocrinol Metab 2020 03;105(3)

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA.

View Article and Find Full Text PDF
March 2020

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.

Authors:
Joy N Tsai Hang Lee Natalie L David Richard Eastell Benjamin Z Leder

Lancet Diabetes Endocrinol 2019 10 22;7(10):767-775. Epub 2019 Aug 22.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Havard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
October 2019

Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT Study.

Authors:
Joy N Tsai Kyle K Nishiyama David Lin Amy Yuan Hang Lee Mary L Bouxsein Benjamin Z Leder

J Bone Miner Res 2019 May 15;34(5):976. Epub 2019 Apr 15.

View Article and Find Full Text PDF
May 2019

Case 8-2018: A Woman with Shock and Labile Blood Pressure.

Authors:
Joseph Loscalzo Nathalie Roy Joy N Tsai

N Engl J Med 2018 05;378(22):2146-2147

Massachusetts General Hospital, Boston, MA

View Article and Find Full Text PDF
May 2018

Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.

Authors:
Joseph Loscalzo Nathalie Roy Ravi V Shah Joy N Tsai Alexis M Cahalane Johannes Steiner James R Stone

N Engl J Med 2018 Mar;378(11):1043-1053

From the Department of Medicine, Brigham and Women's Hospital (J.L.), the Departments of Surgery (N.R.), Medicine (R.V.S., J.N.T., J.S.), Radiology (A.M.C.), and Pathology (J.R.S.), Massachusetts General Hospital, and the Departments of Medicine (J.L., R.V.S., J.N.T., J.S.), Surgery (N.R.), Radiology (A.M.C.), and Pathology (J.R.S.), Harvard Medical School - all in Boston.

View Article and Find Full Text PDF
March 2018

Bone Material Strength Index as Measured by Impact Microindentation in Postmenopausal Women With Distal Radius and Hip Fractures.

Authors:
Tamara D Rozental Kempland C Walley Serkalem Demissie Signe Caksa Adriana Martinez-Betancourt Amber M Parker Joy N Tsai Elaine W Yu Mary L Bouxsein

J Bone Miner Res 2018 04 5;33(4):621-626. Epub 2017 Dec 5.

Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.

View Article and Find Full Text PDF
April 2018

Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.

Authors:
Joy N Tsai Linda A Jiang Hang Lee Didier Hans Benjamin Z Leder

J Clin Densitom 2017 Oct - Dec;20(4):507-512. Epub 2017 Jun 16.

Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
July 2018

Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study.

Authors:
Joy N Tsai Kyle K Nishiyama David Lin Amy Yuan Hang Lee Mary L Bouxsein Benjamin Z Leder

J Bone Miner Res 2017 Oct 10;32(10):2001-2009. Epub 2017 Aug 10.

Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
October 2017

Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).

Authors:
Benjamin Z Leder Joy N Tsai Linda A Jiang Hang Lee

Bone 2017 May 9;98:54-58. Epub 2017 Mar 9.

Harvard Medical School, Endocrine Unit, Massachusetts General Hospital, United States.

View Article and Find Full Text PDF
May 2017

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:
Matthew B Greenblatt Joy N Tsai Marc N Wein

Clin Chem 2017 Feb 9;63(2):464-474. Epub 2016 Dec 9.

Endocrine Unit, Massachusetts General Hospital, Boston, MA.

View Article and Find Full Text PDF
February 2017

Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics.

Authors:
Benjamin Z Leder Joy N Tsai Sherri-Anne Burnett-Bowie Mary L Bouxsein Robert M Neer

Bone 2016 08 5;89:73-74. Epub 2016 May 5.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.

View Article and Find Full Text PDF
August 2016

Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial.

Authors:
Benjamin Z Leder Joy N Tsai Robert M Neer Alexander V Uihlein Paul M Wallace Sherri-Ann M Burnett-Bowie

J Clin Densitom 2016 Jul-Sep;19(3):346-51. Epub 2016 Feb 15.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
February 2018

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Authors:
Benjamin Z Leder Joy N Tsai Alexander V Uihlein Paul M Wallace Hang Lee Robert M Neer Sherri-Ann M Burnett-Bowie

Lancet 2015 Sep 2;386(9999):1147-55. Epub 2015 Jul 2.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
September 2015

Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate.

Authors:
Joy N Tsai Yuli Zhu Katelyn Foley Hang Lee Sherri-Ann Burnett-Bowie Robert M Neer Benjamin Z Leder

J Clin Endocrinol Metab 2015 Jul 1;100(7):2718-23. Epub 2015 May 1.

Department of Medicine (J.T., Y.Z., K.F., S.-A.B.-B., R.N., B.L.), Endocrine Unit, and Biostatistics Center (H.L.), Massachusetts General Hospital, Boston, Massachusetts 02114.

View Article and Find Full Text PDF
July 2015

Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.

Authors:
Joy N Tsai Alexander V Uihlein Sherri-Ann M Burnett-Bowie Robert M Neer Yuli Zhu Nicholas Derrico Hang Lee Mary L Bouxsein Benjamin Z Leder

J Bone Miner Res 2015 Jan;30(1):39-45

Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
January 2015

Effects of escitalopram on markers of bone turnover: a randomized clinical trial.

Authors:
Susan J Diem Hadine Joffe Joseph C Larson Joy N Tsai Katherine A Guthrie Andrea Z LaCroix Kristine E Ensrud Ellen W Freeman Benjamin Z Leder

J Clin Endocrinol Metab 2014 Sep 11;99(9):E1732-7. Epub 2014 Jul 11.

University of Minnesota (S.J.D., K.E.E.), Minneapolis, Minnesota 55415; Brigham and Women's Hospital and Dana Farber Cancer Institute (H.J.), Boston, Massachusetts 02115; Fred Hutchinson Cancer Research Center (J.C.L., A.Z.L.), Seattle, Washington 98109; Massachusetts General Hospital (J.N.T., B.Z.L.), Boston, Massachusetts 02114; Minneapolis Veterans Affairs Health Care System (K.E.E.), Minneapolis, Minnesota 55417; and Perelman School of Medicine (E.W.F.), University of Pennsylvania, Philadelphia, Pennsylvania 19104.

View Article and Find Full Text PDF
September 2014

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Authors:
Benjamin Z Leder Joy N Tsai Alexander V Uihlein Sherri-Ann M Burnett-Bowie Yuli Zhu Katelyn Foley Hang Lee Robert M Neer

J Clin Endocrinol Metab 2014 May 11;99(5):1694-700. Epub 2014 Feb 11.

Department of Medicine, Endocrine Unit (B.Z.L., J.N.T., A.V.U., S.-A.M.B.-B., Y.Z., K.F., R.M.N.) and Biostatistics Center (H.L.), Massachusetts General Hospital, Boston, Massachusetts 02114.

View Article and Find Full Text PDF
May 2014

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Authors:
Joy N Tsai Alexander V Uihlein Hang Lee Ruchit Kumbhani Erica Siwila-Sackman Elizabeth A McKay Sherri-Ann M Burnett-Bowie Robert M Neer Benjamin Z Leder

Lancet 2013 Jul 15;382(9886):50-6. Epub 2013 May 15.

Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
July 2013